Clostridium difficile infection
- PMID: 20697257
- PMCID: PMC2935936
- DOI: 10.1097/MAJ.0b013e3181e939d8
Clostridium difficile infection
Abstract
Clostridium difficile is the leading cause of hospital-acquired diarrhea in Europe and North America and is a serious reemerging pathogen. Recent outbreaks have led to increasing morbidity and mortality and have been associated with a new strain (BI/NAP1/027) of C difficile that produces more toxin than historic strains. With the increasing incidence of C difficile infection, clinicians have also seen a change in the epidemiology with increased infections in previously low-risk populations. This chapter highlights the current knowledge on C difficile virulence, human disease, epidemic outbreaks and optimal treatment strategies.
References
-
- Hall I, O'Toole E. Intestinal flora in newborn infants with a description of a new pathogenic anaerobe, Bacillus difficilis. Am J Dis Child. 1935;49:390.
-
- Kelly CP, LaMont JT. Clostridium difficile - more difficult than ever. N Engl J Med. 2008;359:1932–1940. - PubMed
-
- Bartlett JG. Clostridium difficile: History of its role as an enteric pathogen and the current state of knowledge about the organism. Clin Infect Dis. 1994;18(suppl 4):S265–S272. - PubMed
-
- George WL, Sutter VL, Goldstein EJ, et al. Aetiology of antimicrobial - agent associated colitis. Lancet. 1978;1:802–803. - PubMed
-
- Bartlett JG, Moon N, Chang TW, et al. Role of Clostridium difficile in antibiotic -associated pseudomembranous colitis. Gastroenterology. 1978;75:778–782. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
